Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Marine Drugs
|
July 2, 2021
Symbiotic Associations in Ascidians: Relevance for Functional Innovation and Bioactive Potential
Ana Matos, Agostinho Antunes
Current HIV Research
|
October 26, 2019
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV
Maria João Almeida, Ana Matos
Cureus
|
January 10, 2025
Multisystemic Sarcoidosis in the Primary Care Setting: A Case Report
Ana Matos, Marta Bordalo, Hugo Silva
Medicines (Basel, Switzerland)
|
April 24, 2026
Anticholinergic Burden in Elderly People in Nursing Homes: Cross-Sectional Assessment Using ACB Calculator and CRIDECO Anticholinergic Load Scale
Tânia Nascimento, Maria Ana Matos, Ezequiel Pinto
Cureus
|
November 17, 2025
Current Strategies for Healthy Aging: The Interplay Between Nutrition, Metabolism, and Exercise
Ana Matos, Cezara Tihon, Carolina Costa, et al.
The Journal of Nervous and Mental Disease
|
November 30, 2020
When Obsessive-Compulsive Disorder Mimics Schizophrenia
Mariana Duarte-Mangas, Lucilia Bravo, Ana Matos-Pires
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|
August 13, 2011
[Eosinophilic gastroenteritis with ascites: clinical case report]
Víctor Yep Gamarra, Ana Matos Nova, Augusto Aldave Herrera
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
March 14, 2019
Relationship between HbA1c and capillary blood glucose self-monitoring in type 2 diabetics
Sara Machado, Rui Marques, Edite Nascimento, et al.
Arthritis Care & Research
|
January 23, 2024
Systemic Lupus Erythematosus Disease Activity Score Remission and Low Disease Activity States Discriminate Drug From Placebo and Better Health-Related Quality of Life
Diogo Jesus, Carla Henriques, Ana Matos, et al.
Rheumatology (Oxford, England)
|
April 8, 2026
SLE-DAS responder index: a novel outcome measure with high performance for physician and patient outcomes in anifrolumab phase 2-3 trials
Diogo Jesus, Carla Henriques, Ana Matos, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Marine Drugs
|
July 2, 2021
Symbiotic Associations in Ascidians: Relevance for Functional Innovation and Bioactive Potential
Ana Matos, Agostinho Antunes
Current HIV Research
|
October 26, 2019
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV
Maria João Almeida, Ana Matos
Cureus
|
January 10, 2025
Multisystemic Sarcoidosis in the Primary Care Setting: A Case Report
Ana Matos, Marta Bordalo, Hugo Silva
Medicines (Basel, Switzerland)
|
April 24, 2026
Anticholinergic Burden in Elderly People in Nursing Homes: Cross-Sectional Assessment Using ACB Calculator and CRIDECO Anticholinergic Load Scale
Tânia Nascimento, Maria Ana Matos, Ezequiel Pinto
Cureus
|
November 17, 2025
Current Strategies for Healthy Aging: The Interplay Between Nutrition, Metabolism, and Exercise
Ana Matos, Cezara Tihon, Carolina Costa, et al.
The Journal of Nervous and Mental Disease
|
November 30, 2020
When Obsessive-Compulsive Disorder Mimics Schizophrenia
Mariana Duarte-Mangas, Lucilia Bravo, Ana Matos-Pires
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|
August 13, 2011
[Eosinophilic gastroenteritis with ascites: clinical case report]
Víctor Yep Gamarra, Ana Matos Nova, Augusto Aldave Herrera
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
March 14, 2019
Relationship between HbA1c and capillary blood glucose self-monitoring in type 2 diabetics
Sara Machado, Rui Marques, Edite Nascimento, et al.
Arthritis Care & Research
|
January 23, 2024
Systemic Lupus Erythematosus Disease Activity Score Remission and Low Disease Activity States Discriminate Drug From Placebo and Better Health-Related Quality of Life
Diogo Jesus, Carla Henriques, Ana Matos, et al.
Rheumatology (Oxford, England)
|
April 8, 2026
SLE-DAS responder index: a novel outcome measure with high performance for physician and patient outcomes in anifrolumab phase 2-3 trials
Diogo Jesus, Carla Henriques, Ana Matos, et al.
Page
of 9